孕中期药物终止妊娠后后续早产风险
在阿姆斯特丹大学医学中心开展的队列研究,纳入2008至2023年孕中期使用米非司酮和/或米索前列醇药物终止妊娠且有后续妊娠的个体,评估后续自发性早产风险。后续单胎妊娠中<37周自发性早产率为4.7%,双胎/多胎为16.7%;作者结论认为孕中期药物终止妊娠就后续自发性早产风险而言可视为安全。
要点
- 后续单胎妊娠中<37周自发性早产39/831例(4.7%),多胎妊娠为4/24例(16.7%)。
- 妊娠间隔<3个月与12至24个月比较,<37周自发性早产率6.8% vs 3.2%,校正OR 2.2(95%CI 0.69-7.40),P=.2。
- 药物终止时孕龄>20 0/7周与<12 0/7至15 6/7周比较,<37周自发性早产率5.9% vs 2.6%,校正OR 2.2(95%CI 0.92-5.4),P=.07。
核心结论
- 作者结论认为孕中期药物终止妊娠就后续自发性早产风险而言可视为安全。
- 作者建议患者咨询应包含留出时间进行宫颈重塑以降低早产风险的重要性,尤其对终止时孕龄较高者。
研究设计与样本
- 在阿姆斯特丹大学医学中心开展的队列研究,纳入2008至2023年孕中期使用米非司酮和/或米索前列醇药物终止妊娠且至2024年有已知后续妊娠的个体。
- 排除其他终止方法(如剖宫产、子宫切除、刮宫或Foley导管)及因宫内胎死或未足月胎膜早破而药物终止妊娠者。
- 1438例符合条件,1033例已知有后续妊娠,其中986例结局可用(962例单胎妊娠和24例多胎妊娠)。
主要发现
- 后续单胎妊娠超过16周者中,<37周自发性早产39/831例(4.7%)。
- 多胎妊娠中<37周自发性早产4/24例(16.7%)。
- 单胎妊娠中,妊娠间隔<3个月与12至24个月比较,<37周自发性早产率6.8% vs 3.2%,校正OR 2.2(95%CI 0.69-7.40),P=.2,未达统计学显著。
- 单胎妊娠中,药物终止时孕龄>20 0/7周与<12 0/7至15 6/7周比较,<37周自发性早产率5.9% vs 2.6%,校正OR 2.2(95%CI 0.92-5.4),P=.07,未达统计学显著。
- 将药物终止时孕龄(周)作为连续变量纳入线性回归模型,与后续自发性早产呈显著正相关(B=0.56;R2=0.31;P=.04)。
关键数值与推荐
- 主要结局为后续妊娠<37周自发性早产。
- 次要结局包括后续<16周流产、重复终止妊娠,以及<37、<32和<28周总早产、自发性早产和医源性早产率。
- 按妊娠间隔、药物终止时孕龄和产后手术干预进行亚组分析,采用logistic回归估计比值比和95%置信区间并校正混杂因素。
- 后续单胎和多次妊娠分别评估。
临床怎么用
- 作者建议患者咨询应包含留出时间进行宫颈重塑以降低早产风险的重要性,尤其对终止时孕龄较高者。
- 原文未据此给出其他推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Medical termination of pregnancy (using mifepristone and misoprostol) is a commonly performed health intervention. High-quality cohort studies are warranted to investigate the association between second-trimester medical termination of pregnancy and subsequent pregnancy outcomes. OBJECTIVE: This study aimed to assess the risk of subsequent spontaneous preterm birth after second-trimester medical termination of pregnancy. STUDY DESIGN: This was a cohort study performed at the Amsterdam University Medical Center of the University of Amsterdam. All individuals who underwent a second-trimester medical termination of pregnancy between 2008 and 2023 using mifepristone and/or misoprostol and had a known subsequent pregnancy up to 2024 were included. The exclusion criteria were other methods of termination (eg, cesarean delivery, hysterectomy, curettage, or Foley catheter) and indication for medical termination of pregnancy due to intrauterine fetal demise or preterm premature rupture of membranes. The primary outcome was spontaneous preterm birth at <37 weeks of gestation in the subsequent pregnancy. The secondary outcomes included subsequent miscarriage at <16 weeks of gestation, repeated termination, and rates of total, spontaneous, and iatrogenic preterm births at <37, <32, and <28 weeks of gestation. Subgroup analyses were performed on the interpregnancy interval, gestational age at medical termination of pregnancy, and postpartum surgical interventions using logistic regression estimating odds ratios and 95% confidence intervals, with adjustment for confounders. Subsequent singleton and multiple pregnancies were assessed separately. RESULTS: Of 1438 eligible cases, 1033 were known to have a subsequent pregnancy, of which 986 outcomes were available (962 singleton pregnancies and 24 multiple pregnancies). In subsequent singleton pregnancies exceeding 16 weeks of gestation, spontaneous preterm birth at <37 weeks of gestation occurred in 39 of 831 cases (4.7%). In multiple pregnancies, spontaneous preterm birth at <37 weeks of gestation occurred in 4 of 24 cases (16.7%). In subsequent singleton pregnancies, the rates of spontaneous preterm birth at <37 weeks of gestation were higher after an interpregnancy interval of <3 months than an interpregnancy interval of 12 to 24 months (6.8% vs 3.2%, respectively; adjusted odds ratio, 2.2 [95% confidence interval, 0.69-7.40]; P=.2) and higher for a gestational age of >20 0/7 weeks at medical termination of pregnancy than a gestational age of <12 0/7 to 15 6/7 weeks (5.9% vs 2.6%, respectively; adjusted odds ratio, 2.2 [95% confidence interval, 0.92-5.4]; P=.07). However, both results were not statistically significant. However, when gestational age at medical termination of pregnancy was included as a continuous variable (in weeks) in a linear regression model, a significant positive association with subsequent spontaneous preterm birth was found (B=0.56; R2=0.31; P=.04). CONCLUSION: Second-trimester medical termination of pregnancy can be considered safe with regard to subsequent spontaneous preterm birth risk. As recommended after preterm and term births, patient counseling should include the importance of allowing time for cervical remodeling to mitigate preterm birth risks, particularly for those with a medical termination of pregnancy at higher gestational ages.
引用
- van Gils AL, Koorn I, Jonker JG, et al. Subsequent risk of preterm birth after second-trimester medical termination of pregnancy. Am J Obstet Gynecol. 2025. PMID: 40398526. doi:10.1016/j.ajog.2025.05.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。